Page last updated: 2024-10-25

debrisoquin and Chronic Illness

debrisoquin has been researched along with Chronic Illness in 5 studies

Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.

Research Excerpts

ExcerptRelevanceReference
" Determination of debrisoquine oxidation phenotype was carried out in 119 healthy subjects, 135 patients with chronic bronchitis and 153 patients with lung cancer, all of Caucasian origin."3.68Lack of a relationship between the polymorphism of debrisoquine oxidation and lung cancer. ( Barre, J; Bechtel, P; Brochard, P; Dalphin, JC; de Cremoux, H; Depierre, A; Duche, JC; Joanne, C; Tillement, JP, 1991)
"Perhexiline maleate is an antianginal agent which depends on hepatic oxidation for its elimination."1.27Impaired oxidation of debrisoquine in patients with perhexiline liver injury. ( Morgan, MY; Oates, NS; Reshef, R; Shah, RR; Sherlock, S; Smith, RL, 1984)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morgan, MY1
Reshef, R1
Shah, RR1
Oates, NS1
Smith, RL1
Sherlock, S1
Stanchev, A1
Shishmanova, Iu1
Sheĭtanov, I1
Georgiev, I1
Adi, FC1
Eze, CJ1
Anwunah, A1
Duche, JC1
Joanne, C1
Barre, J1
de Cremoux, H1
Dalphin, JC1
Depierre, A1
Brochard, P1
Tillement, JP1
Bechtel, P1
Bückert, A1
Schweda, E1
Vich, V1

Trials

2 trials available for debrisoquin and Chronic Illness

ArticleYear
[Treatment of hypertension with the preparation Tendor].
    Vutreshni bolesti, 1977, Volume: 16, Issue:6

    Topics: Adult; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Debrisoquin; Drug Evaluation; Fema

1977
Comparison of debrisoquine and guanethidine in treatment of hypertension.
    British medical journal, 1975, Mar-01, Volume: 1, Issue:5956

    Topics: Administration, Oral; Adult; Body Weight; Chronic Disease; Debrisoquin; Economics, Medical; Ejaculat

1975

Other Studies

3 other studies available for debrisoquin and Chronic Illness

ArticleYear
Impaired oxidation of debrisoquine in patients with perhexiline liver injury.
    Gut, 1984, Volume: 25, Issue:10

    Topics: Adolescent; Adult; Aged; Angina Pectoris; Chemical and Drug Induced Liver Injury; Chronic Disease; D

1984
Lack of a relationship between the polymorphism of debrisoquine oxidation and lung cancer.
    British journal of clinical pharmacology, 1991, Volume: 31, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Bronchitis; Chronic Disease; Debrisoquin; Female; Humans; Lung Neopl

1991
[Therapeutic results with the hypotensive agent Declinax (debrisoquin) in mild and medium forms of hypertension].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1973, Nov-20, Volume: 62, Issue:47

    Topics: Antihypertensive Agents; Blood Pressure; Chronic Disease; Debrisoquin; Diuretics; Drug Therapy, Comb

1973